1. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy.

   Emblem, K. E., Mouridsen, K., Bjornerud, A., Farrar, C. T., Jennings, D., Borra, R. J. H., Wen, P. Y., Ivy, P., Batchelor, T. T., Rosen, B. R., Jain, R. K. & Sorensen, A. G., 15-Apr-2013, In : Cancer Research. 73, 8, 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

2. T-1- and T-2*-dominant extravasation correction in DSC-MRI: Part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients

   Emblem, K. E., Bjornerud, A., Mouridsen, K., Borra, R. J. H., Batchelor, T. T., Jain, R. K. & Sorensen, A. G., Oct-2011, In : Journal of Cerebral Blood Flow and Metabolism. 31, 10, p. 2054-2064 11 p.

   Research output: Contribution to journal › Article › Academic › peer-review

3. Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy

   Emblem, K. E., Mouridsen, K., Bjornerud, A., Farrar, C. T., Jennings, D., Borra, R. J. H., Wen, P. Y., Ivy, P., Batchelor, T. T., Rosen, B. R., Jain, R. K. & Sorensen, A. G., Sep-2013, In : Nature Medicine. 19, 9, p. 1178-1183 6 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (3) »